Antibiotic disc | Inhibition Diameter (mm), resistance Profile to imipenem and meropenem only, production of ESBL and Carbapenemase, results for 10 clinical isolates | |||||||||||||
K1 | K2 | K3 | K4 | K7 | K10 | K11 | K13 | K14 | K15 | K16 | K20 | Kp NCTC 13438 | ATCC 25922 | |
IMP, 10 μg | 22 | 21 | 21 | 21 | 22 | 23 | 22 | 26 | 23 | 23 | 9 | 12 | 9 | 26 |
I | I | I | I | I | S | I | S | S | S | R | R | R | S | |
MER, 10 μg | 25 | 25 | 26 | 23 | 25 | 25 | 26 | 28 | 26 | 26 | 6 | 6 | 6 | 30 |
S | S | S | S | S | S | S | S | S | S | R | R | R | S | |
ESBL (SYNERGISTIC ACTION) | + | + | + | + | − | + | + | + | + | + | − | − | − | − |
CP | − | − | − | − | − | − | − | − | − | − | + | + | + | − |